Becker's muscular dystrophy: Difference between revisions

Jump to navigation Jump to search
← Older edit
VisualWikitext
MoisesRomo (talk | contribs)
751 edits
No edit summary
MoisesRomo (talk | contribs)
751 edits
No edit summary
 
(6 intermediate revisions by the same user not shown)
Line 1: Line 1:
<br />{{SI}}
<br />{{SI}}
{{CMG}}; '''Associate Editor(s)-in-Chief:''' [[User:MoisesRomo|Moises Romo, M.D.]]
{{CMG}}; '''Associate Editor(s)-in-Chief:''' [[User:MoisesRomo|Moises Romo, M.D.]]
<br />


== Overview ==
== Overview ==
Former "[[pseudohypertrophic muscular dystrophy]]", now Becker's muscular [[dystrophy]], is a [[Genetic disorder|genetic]] [[neuromuscular]] condition characterized by slowly progresive [[Muscle weakness|weakness]] and [[atrophy]] of [[Skeletal muscle|skeletal]] (mostly legs and pelvis) and [[cardiac muscles]].
Former "[[pseudohypertrophic muscular dystrophy]]", now Becker's muscular [[dystrophy]], is a [[Genetic disorder|genetic]] [[neuromuscular]] condition characterized by slowly progresive [[Muscle weakness|weakness]] and [[atrophy]] of [[Skeletal muscle|skeletal]] (mostly legs and pelvis) and [[cardiac muscles]].


== Historical Perspective ==
== Historical Perspective ==


* Becker's muscular [[dystrophy]] was first described by Peter Emil Becker, a German [[neurologist]], [[psychiatrist]] and [[geneticist]], in 1953 with his thesis called ‘‘Dystrophia Musculorum Progessiva: A [[Genetic]] and Clinical Investigation of the Muscular Dystrophies’’, after his work was interrumpted in 1942 due to [[World war|WWII]] recruitment.
* Becker's muscular [[dystrophy]] was first described by Peter Emil Becker, a German [[neurologist]], [[psychiatrist]] and [[geneticist]], in 1953 with his thesis called ‘‘Dystrophia Musculorum Progessiva: A [[Genetic]] and Clinical Investigation of the Muscular Dystrophies’’, after his work was interrumpted in 1942 due to [[World war|WWII]] recruitment.<ref name="pmid23576413">{{cite journal |vauthors=Zeidman LA, Kondziella D |title=Peter Becker and his Nazi past: the man behind Becker muscular dystrophy and Becker myotonia |journal=J. Child Neurol. |volume=29 |issue=4 |pages=514–9 |date=April 2014 |pmid=23576413 |doi=10.1177/0883073813482773 |url=}}</ref><ref name="urlGuillaume Benjamin Amand Duchenne de Boulogne">{{cite web |url=http://www.whonamedit.com/doctor.cfm/950.html |title=Guillaume Benjamin Amand Duchenne de Boulogne |format= |work= |accessdate=}}</ref>
* Before Becker, in the 1860's, French [[neurologist]] [[Guillaume Benjamin Amand Duchenne]] described in detail a slowly progessive [[Muscle weakness|muscular weakness]] in a boy, later known as [[Duchenne muscular dystrophy]].
* Before Becker, in the 1860's, French [[neurologist]] [[Guillaume Benjamin Amand Duchenne]] described in detail a slowly progessive [[Muscle weakness|muscular weakness]] in a boy, later known as [[Duchenne muscular dystrophy]].<ref name="pmid31789220">{{cite journal |vauthors=Mercuri E, Bönnemann CG, Muntoni F |title=Muscular dystrophies |journal=Lancet |volume=394 |issue=10213 |pages=2025–2038 |date=November 2019 |pmid=31789220 |doi=10.1016/S0140-6736(19)32910-1 |url=}}</ref>
* The association between [[genetic mutations]] and Duchenne [[muscular dystrophy]] was made in 1986.
* The association between [[genetic mutations]] and Duchenne [[muscular dystrophy]] was made in 1986.<ref name="HoffmanBrown1987">{{cite journal|last1=Hoffman|first1=Eric P.|last2=Brown|first2=Robert H.|last3=Kunkel|first3=Louis M.|title=Dystrophin: The protein product of the duchenne muscular dystrophy locus|journal=Cell|volume=51|issue=6|year=1987|pages=919–928|issn=00928674|doi=10.1016/0092-8674(87)90579-4}}</ref>
* In 1987, [[dystrophin]] gene on [[X chromosome]] were first implicated in the [[pathogenesis]] of Becker's [[muscular dystrophy]]. <br />
* In 1987, [[dystrophin]] gene on [[X chromosome]] were first implicated in the [[pathogenesis]] of Becker's [[muscular dystrophy]].<ref name="HoffmanBrown1987" /><br />


== Pathophysiology ==
== Pathophysiology ==


* The [[pathogenesis]] of Becker's muscular [[dystrophy]] is characterized by muscle [[Muscle weakness|weakness]] and [[pseudohypertrophy]] (mostly [[proximal]]), [[Hypertrophic cardiomyopathy|cardiomyopathy]], elevated [[CK]] and skelletal [[Deformity|deformities]].
* The [[pathogenesis]] of Becker's muscular [[dystrophy]] is characterized by muscle [[Muscle weakness|weakness]] and [[pseudohypertrophy]] (mostly [[proximal]]), [[Hypertrophic cardiomyopathy|cardiomyopathy]], elevated [[CK]] and skelletal [[Deformity|deformities]].<ref name="SarkozyBushby20143">{{cite journal|last1=Sarkozy|first1=A.|last2=Bushby|first2=K.|last3=Mercuri|first3=E.|title=Muscular Dystrophies|year=2014|doi=10.1016/B978-0-12-801238-3.05597-5}}</ref>
* Becker's muscular dystrophy is inherited in an [[X-linked]] recessive fashion.
* Becker's muscular dystrophy is inherited in an [[X-linked]] recessive fashion.<ref name="urlBecker muscular dystrophy | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program4">{{cite web |url=https://rarediseases.info.nih.gov/diseases/5900/becker-muscular-dystrophy |title=Becker muscular dystrophy &#124; Genetic and Rare Diseases Information Center (GARD) – an NCATS Program |format= |work= |accessdate=}}</ref>
* Becker's muscular [[dystrophy]] is caused by a [[mutation]] in the gene [[DMD]], one of the largest [[genes]] in humans. This [[gene]] encodes for the [[3685Y]] [[aminoacid]] protein called [[dystrophin]], wich can be found in [[Skeletal muscle|skeletal]] and [[Cardiac muscle cell|cardiac muscle]], among other tisues.  This [[mutation]] produces a truncated [[dystrophin]] [[protein]] that will translate into a decreased but not incomplete functionality (difference from [[Duchenne muscular dystrophy|Duchenne]]). Around 33% of patients with Becker's muscular dystrophy have [[de novo]] [[Mutation|mutations]]. Point [[Mutation|mutations]] and [[duplications]] appear mostly from [[spermatogenesis]] while deletions arise from [[oogenesis]] in most of te cases.   
* Becker's muscular [[dystrophy]] is caused by a [[mutation]] in the gene [[DMD]], one of the largest [[genes]] in humans.<ref name="pmid24305447">{{cite journal |vauthors=Wicklund MP |title=The muscular dystrophies |journal=Continuum (Minneap Minn) |volume=19 |issue=6 Muscle Disease |pages=1535–70 |date=December 2013 |pmid=24305447 |doi=10.1212/01.CON.0000440659.41675.8b |url=}}</ref> This [[gene]] encodes for the [[3685Y]] [[aminoacid]] protein called [[dystrophin]], wich can be found in [[Skeletal muscle|skeletal]] and [[Cardiac muscle cell|cardiac muscle]], among other tisues.<ref name="pmid24305447" /> This [[mutation]] produces a truncated [[dystrophin]] [[protein]] that will translate into a decreased but not incomplete functionality (difference from [[Duchenne muscular dystrophy|Duchenne]]).<ref name="IannacconeCastro2013">{{cite journal|last1=Iannaccone|first1=Susan T.|last2=Castro|first2=Diana|title=Congenital Muscular Dystrophies and Congenital Myopathies|journal=CONTINUUM: Lifelong Learning in Neurology|volume=19|year=2013|pages=1509–1534|issn=1080-2371|doi=10.1212/01.CON.0000440658.03557.f1}}</ref> <ref name="pmid203012986">{{cite journal |vauthors=Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, Darras BT, Urion DK, Ghosh PS |title= |journal= |volume= |issue= |pages= |date= |pmid=20301298 |doi= |url=}}</ref>
* On microscopic [[Histopathology|histopathological]] analysis, endomysial fibrosis with fatty replacement of [[muscle]] in later stages, [[inflammation]], increased internal [[nuclei]], [[Myofiber|myofibe]]<nowiki/>r cleavage with [[necrosis]], and [[phagocytosis]] are characteristic findings of Becker's muscular dystrophy.<ref name=":0" /> <br />
*Around 33% of patients with Becker's muscular dystrophy have [[de novo]] [[Mutation|mutations]].<ref name="pmid236206492" /> Point [[Mutation|mutations]] and [[duplications]] appear mostly from [[spermatogenesis]] while deletions arise from [[oogenesis]] in most of te cases.<ref name="pmid203012983">{{cite journal |vauthors=Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, Darras BT, Urion DK, Ghosh PS |title= |journal= |volume= |issue= |pages= |date= |pmid=20301298 |doi= |url=}}</ref> 
* On microscopic [[Histopathology|histopathological]] analysis, endomysial fibrosis with fatty replacement of [[muscle]] in later stages, [[inflammation]], increased internal [[nuclei]], [[Myofiber|myofibe]]<nowiki/>r cleavage with [[necrosis]], and [[phagocytosis]] are characteristic findings of Becker's muscular dystrophy.<ref name="SarkozyBushby20143" /><br />


== Clinical Features ==
== Clinical Features ==
Unlike [[Duchenne muscular dystrophy]], Becker's muscular dystrophy (BMD) [[phenotype]] presents at a later age, widely variable onset from early [[childhood]] to late [[adulthood]], most of them falling in [[puberty]] range. Most of the patients will requiere a wheelchair after age 16.
Unlike [[Duchenne muscular dystrophy]], Becker's muscular dystrophy (BMD) [[phenotype]] presents at a later age, widely variable onset from early [[childhood]] to late [[adulthood]], most of them falling in [[puberty]] range. Most of the patients will requiere a wheelchair after age 16.<ref name="pmid203012984">{{cite journal |vauthors=Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, Darras BT, Urion DK, Ghosh PS |title= |journal= |volume= |issue= |pages= |date= |pmid=20301298 |doi= |url=}}</ref>


Clinical presentation Becker's muscular [[dystrophy]] include:
Clinical presentation Becker's muscular [[dystrophy]] include:


* Progressive symmetric muscle weakness, with a predilection in proximal muscles (eg. pelvic, legs, shoulders)<ref name="pmid203012987" />
* Progressive symmetric muscle weakness, with a predilection in proximal muscles (eg. pelvic, legs, shoulders)<ref name="pmid203012984" />
*[[Congestive heart failure]]
*[[Congestive heart failure]]<ref name="SarkozyBushby20142" /><ref name="pmid203012988" /><ref name="pmid243054473">{{cite journal |vauthors=Wicklund MP |title=The muscular dystrophies |journal=Continuum (Minneap Minn) |volume=19 |issue=6 Muscle Disease |pages=1535–70 |date=December 2013 |pmid=24305447 |doi=10.1212/01.CON.0000440659.41675.8b |url=}}</ref>
*Calf [[hypertrophy]]<ref name="pmid203012987" />
*Calf [[hypertrophy]]<ref name="pmid203012984" /><ref name="pmid17162189" />
*[[Cramp|Cramping]] and [[muscle]] pain after exercise<ref name="pmid203012987" />
*[[Cramp|Cramping]] and [[muscle]] pain after exercise<ref name="SarkozyBushby20142">{{cite journal|last1=Sarkozy|first1=A.|last2=Bushby|first2=K.|last3=Mercuri|first3=E.|title=Muscular Dystrophies|year=2014|doi=10.1016/B978-0-12-801238-3.05597-5}}</ref><ref name="pmid17162189" />
* Flexion contractures<ref name="pmid203012987" />
* Flexion contractures<ref name="pmid203012984" /><ref name="pmid17162189" />
* Normal neck [[Flexion|flexor]] muscle [[Strength training|strength]] (differenting factor of BMD from [[Duchenne muscular dystrophy|DMD]])<ref name="pmid203012987" />
* Normal neck [[Flexion|flexor]] muscle [[Strength training|strength]] (differenting factor of BMD from [[Duchenne muscular dystrophy|DMD]])<ref name="pmid203012988">{{cite journal |vauthors=Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, Darras BT, Urion DK, Ghosh PS |title= |journal= |volume= |issue= |pages= |date= |pmid=20301298 |doi= |url=}}</ref>


There is an abcense of fasciculations, and this finding may exclude BMD<ref name="pmid203012987" />
There is an abcense of fasciculations, and this finding may exclude BMD<ref name="SarkozyBushby20142" /><ref name="pmid203012988" />


[[CNS]] is rarely afected in Becker's muscular [[dystrophy]], for this reason, [[Intelligence test|intelligence]] is usually spared.
[[CNS]] is rarely afected in Becker's muscular [[dystrophy]], for this reason, [[Intelligence test|intelligence]] is usually spared.<ref name="pmid203012984" /><ref name="SarkozyBushby2014">{{cite journal|last1=Sarkozy|first1=A.|last2=Bushby|first2=K.|last3=Mercuri|first3=E.|title=Muscular Dystrophies|year=2014|doi=10.1016/B978-0-12-801238-3.05597-5}}</ref>


Most of women are [[asymptomatic]] [[carriers]], with very rare cases presenting the classic [[Symptom|symptoms]].<br />
Most of women are [[asymptomatic]] [[carriers]], with very rare cases presenting the classic [[Symptom|symptoms]].<ref name="pmid203012984" /><ref name="pmid203012986" /><br />


== Differentiating Becker's muscular dystrophy from other Diseases ==
== Differentiating Becker's muscular dystrophy from other Diseases ==
Becker's muscular dystrophy must be differentiated from other diseases that cause skelletal and cardiac muscle afection, such as:
Becker's muscular dystrophy must be differentiated from other diseases that cause skelletal and cardiac muscle afection, such as:


* '''[[Duchenne muscular dystrophy]]'''. Presents with most of the symptoms of Beckers muscular [[dystrophy]] but with an earlier and more severe onset, most of them having [[Symptom|symptoms]] from age 3 ([[Gowers' sign|Gower's sign]]); by convention, if a patient with a suspected [[dystrophinopathy]] stops walking before 12 years of age, he has DMD. Another diferentiating factor is the normal strength of neck flexor muscles in BMD<ref name="pmid203012987" />
* [[Duchenne muscular dystrophy]]. Presents with most of the symptoms of Beckers muscular [[dystrophy]] but with an earlier and more severe onset, most of them having [[Symptom|symptoms]] from age 3 ([[Gowers' sign|Gower's sign]]); by convention, if a patient with a suspected [[dystrophinopathy]] stops walking before 12 years of age, he has DMD.<ref name="pmid243054473" /> Another diferentiating factor is the normal strength of neck flexor muscles in BMD.<ref name="pmid203012985">{{cite journal |vauthors=Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, Darras BT, Urion DK, Ghosh PS |title= |journal= |volume= |issue= |pages= |date= |pmid=20301298 |doi= |url=}}</ref>
* [[Limb-girdle muscular dystrophy|'''Limb-girdle muscular dystrophy''' '''(LGMD)''']]. Is a group of [[inherited]] [[autosomal]] conditions that are clinically similar to [[dystrophynopathies]] (muscle [[Muscle weakness|weakness]] and [[wasting]]) but occur in both sexes. They are caused by a [[gene]] [[mutation]] that encodes [[sarcoglycans]].
* [[Limb-girdle muscular dystrophy|Limb-girdle muscular dystrophy (LGMD)]]. Is a group of [[inherited]] [[autosomal]] conditions that are clinically similar to [[dystrophynopathies]] (muscle [[Muscle weakness|weakness]] and [[wasting]]) but occur in both sexes. They are caused by a [[gene]] [[mutation]] that encodes [[sarcoglycans]].
* [[Emery-Dreifuss muscular dystrophy|'''Emery-Dreifuss muscular dystrophy''' '''(EDMD)''']]. Is a [[Neuromuscular disease|neuromuscular]] disorder that may be inherited in an [[Autosomal chromosome|autosomal]] or [[X-linked]] mode. The classic clinical triad encompasses  incidious muscle [[Muscle weakness|weakness]] and [[wasting]] with predilection in the humero-peroneal distribution, joint [[Contracture|contractures]] in childhood, and cardiac afection that includes [[Palpitation|palpitations]], and syncope.
* [[Emery-Dreifuss muscular dystrophy|Emery-Dreifuss muscular dystrophy (EDMD)]]. Is a [[Neuromuscular disease|neuromuscular]] disorder that may be inherited in an [[Autosomal chromosome|autosomal]] or [[X-linked]] mode. The classic clinical triad encompasses  incidious muscle [[Muscle weakness|weakness]] and [[wasting]] with predilection in the humero-peroneal distribution, joint [[Contracture|contractures]] in childhood, and cardiac afection that includes [[Palpitation|palpitations]], and syncope.<ref name="pmid17162189" />
* [[Spinal muscular atrophy|'''Spinal muscular atrophy''' '''(SMA)''']]. Presents with muscle [[atrophy]], delayed [[weight]] and [[height]] gain, [[restrictive lung disease]], [[scoliosis]], [[Contractures|joint contractures]], and [[sleep]] difficulties. Is inherited in an [[autosomal recessive]] mode.<ref name="pmid203012982" />
* [[Spinal muscular atrophy|Spinal muscular atrophy(SMA)]]. Presents with muscle [[atrophy]], delayed [[weight]] and [[height]] gain, [[restrictive lung disease]], [[scoliosis]], [[Contractures|joint contractures]], and [[sleep]] difficulties. Is inherited in an [[autosomal recessive]] mode.<ref name="pmid203012985" /><ref name="pmid17162189" />
* [[Dilated cardiomyopathy|'''Dilated cardiomyopathy''' '''(DCM)''']]. Familial variants may be inherited in an [[Autosomal chromosome|autosomal]] ([[Dominant gene|dominant]] or [[Recessive gene|recessive]]), or an [[X-linked]] fashion. Presents with symptoms of [[dyspnea]] and poor [[Exercise stress testing|exercise tolerance]].
* [[Dilated cardiomyopathy|Dilated cardiomyopathy(DCM)]]. Familial variants may be inherited in an [[Autosomal chromosome|autosomal]] ([[Dominant gene|dominant]] or [[Recessive gene|recessive]]), or an [[X-linked]] fashion. Presents with symptoms of [[dyspnea]] and poor [[Exercise stress testing|exercise tolerance]].
* '''[[Barth syndrome]].''' Is an X-linked disorder characterized by prepubertal [[growth delay]] followed by a growth spurt, muscle [[Muscle weakness|weakness]], [[Cardiomyopathy, Dilated|cardiomyopathy]], [[neutropenia]],  and [[facial gestalt]].<br />
* [[Barth syndrome]]. Is an X-linked disorder characterized by prepubertal [[growth delay]] followed by a growth spurt, muscle [[Muscle weakness|weakness]], [[Cardiomyopathy, Dilated|cardiomyopathy]], [[neutropenia]],  and [[facial gestalt]].<br />


== Screening ==
== Screening ==


* [[Prenatal testing|Prenatal molecular genetic testing]] is recomended in couples planning to [[Pregnancy|conceive]] and have family members who are afected by or are [[Genetic carrier|carriers]] of a dystrophinopathy.
* [[Prenatal testing|Prenatal molecular genetic testing]] is recomended in couples planning to [[Pregnancy|conceive]] and have family members who are afected by or are [[Genetic carrier|carriers]] of a dystrophinopathy.<ref name="pmid2030129811">{{cite journal |vauthors=Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, Darras BT, Urion DK, Ghosh PS |title= |journal= |volume= |issue= |pages= |date= |pmid=20301298 |doi= |url=}}</ref>
* [[In utero|In-utero]] fetal [[muscle biopsy]] has also been realized under couples request for [[fetuses]] with a high [[probability]] of beign affected and inconclusive [[genetic linkage]].
* [[In utero|In-utero]] fetal [[muscle biopsy]] has also been realized under couples request for [[fetuses]] with a high [[probability]] of beign affected and inconclusive [[genetic linkage]].<ref name="pmid17041906">{{cite journal |vauthors=Deburgrave N, Daoud F, Llense S, Barbot JC, Récan D, Peccate C, Burghes AH, Béroud C, Garcia L, Kaplan JC, Chelly J, Leturcq F |title=Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene |journal=Hum. Mutat. |volume=28 |issue=2 |pages=183–95 |date=February 2007 |pmid=17041906 |doi=10.1002/humu.20422 |url=}}</ref>
* It is important to identify females at risk to be [[heterozygous]] of a [[dystrophinopathy]], in order to manage possible [[Cardiomyopathies|cardiac]] complications; this can be done by [[Genetic testing|molecular genetic testing]], [[CK]] measurements, and [[Genetic linkage|linkage]] analysis.
* It is important to identify females at risk to be [[heterozygous]] of a [[dystrophinopathy]], in order to manage possible [[Cardiomyopathies|cardiac]] complications; this can be done by [[Genetic testing|molecular genetic testing]], [[CK]] measurements, and [[Genetic linkage|linkage]] analysis.<ref name="pmid17041906" /><ref name="pmid2030129811" />


<br />
<br />
Line 60: Line 59:


* The [[prevalence]] of Becker's muscular dystrophy is approximately 1-3 per 100,000 individuals.
* The [[prevalence]] of Becker's muscular dystrophy is approximately 1-3 per 100,000 individuals.
* The [[incidence]] of Becker's muscular dystrophy is approximately 3-6 per 100,000 male [[births]] worldwide.<ref name=":1" /><ref name=":2" />
* The [[incidence]] of Becker's muscular dystrophy is approximately 3-6 per 100,000 male [[births]] worldwide.


=== Age ===
=== Age ===
Becker's muscular dystrophy is diagnosed in 85% of patients by age 25.
Becker's muscular dystrophy is diagnosed in 85% of patients by age 25.<ref name="pmid1673177">{{cite journal |vauthors=Bushby KM, Thambyayah M, Gardner-Medwin D |title=Prevalence and incidence of Becker muscular dystrophy |journal=Lancet |volume=337 |issue=8748 |pages=1022–4 |date=April 1991 |pmid=1673177 |doi=10.1016/0140-6736(91)92671-n |url=}}</ref>


=== Gender ===
=== Gender ===
Becker's muscular dystrophy affects mostly men, women are [[Genetic carrier|carriers]] almost exclusively (except rare situation).
Becker's muscular dystrophy affects mostly men, women are [[Genetic carrier|carriers]] almost exclusively (except rare situation).<ref name="pmid2030129813">{{cite journal |vauthors=Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, Darras BT, Urion DK, Ghosh PS |title= |journal= |volume= |issue= |pages= |date= |pmid=20301298 |doi= |url=}}</ref>


=== Race ===
=== Race ===


* Becker's muscular dystrophy usually affects individuals of the hispanic race.<ref name="pmid19834452" />
* Becker's muscular dystrophy usually affects individuals of the hispanic race.<ref name="urlPrevalence of Duchenne / Becker Muscular Dystrophies | CDC">{{cite web |url=https://www.cdc.gov/ncbddd/musculardystrophy/features/key-findings-population-duchenne.html |title=Prevalence of Duchenne / Becker Muscular Dystrophies &#124; CDC |format= |work= |accessdate=}}</ref><ref name="pmid198344522">{{cite journal |vauthors= |title=Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years - four states, 2007 |journal=MMWR Morb. Mortal. Wkly. Rep. |volume=58 |issue=40 |pages=1119–22 |date=October 2009 |pmid=19834452 |doi= |url=}}</ref>
* Asian individuals are less likely to develop Becker's muscular dystrophy.<ref name=":3" />
* Asian individuals are less likely to develop Becker's muscular dystrophy.<ref name="urlPrevalence of Duchenne / Becker Muscular Dystrophies | CDC" /><ref name="pmid198344522" />


== Risk Factors ==
== Risk Factors ==


* Becker's muscular dystrophy is developed in the majority of cases from males who are born from [[genetic carrier]] mothers or by [[Mutation|spontaneous mutation]],<ref name="pmid23620649" /> there has not been any [[Risk factor|risk factors]] implicated for a [[DMD]] gene mutation.
* Becker's muscular dystrophy is developed in the majority of cases from males who are born from [[genetic carrier]] mothers or by [[Mutation|spontaneous mutation]], there has not been any [[Risk factor|risk factors]] implicated for a [[DMD]] gene mutation.<ref name="pmid198344523">{{cite journal |vauthors= |title=Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years - four states, 2007 |journal=MMWR Morb. Mortal. Wkly. Rep. |volume=58 |issue=40 |pages=1119–22 |date=October 2009 |pmid=19834452 |doi= |url=}}</ref>
* Studies have found that several [[Genetics|genetic]] [[polymorphisms]] and [[Mutation|mutations]] may be a factor for Becker's muscular dystrophy progression, but further [[research]] is necessary to draw conclusions. <br />
* Studies have found that several [[Genetics|genetic]] [[polymorphisms]] and [[Mutation|mutations]] may be a factor for Becker's muscular dystrophy progression, but further [[research]] is necessary to draw conclusions.<ref name="pmid27018093">{{cite journal |vauthors=Barakat-Haddad C, Shin S, Candundo H, Lieshout PV, Martino R |title=A systematic review of risk factors associated with muscular dystrophies |journal=Neurotoxicology |volume=61 |issue= |pages=55–62 |date=July 2017 |pmid=27018093 |doi=10.1016/j.neuro.2016.03.007 |url=}}</ref> <br />
== Natural History, Complications and Prognosis ==
== Natural History, Complications and Prognosis ==


* The majority of patients with Becker's muscular [[dystrophy]] remain [[asymptomatic]] until [[adolescence]].
* The majority of patients with Becker's muscular [[dystrophy]] remain [[asymptomatic]] until [[adolescence]].<ref name="pmid975594">{{cite journal |vauthors=Emery AE, Skinner R |title=Clinical studies in benign (Becker type) X-linked muscular dystrophy |journal=Clin. Genet. |volume=10 |issue=4 |pages=189–201 |date=October 1976 |pmid=975594 |doi=10.1111/j.1399-0004.1976.tb00033.x |url=}}</ref>
* Early clinical features include calf hypertrophy, difficulty rising from a chair, [[Anatomical terms of location|proximal]] muscle [[Muscle weakness|weakness]], climbing stairs, sustaining [[Imbalance|balance]], elevating arms, and in later stages [[heart failure]].<ref name="pmid20301298" />
* Early clinical features include calf hypertrophy, difficulty rising from a chair, [[Anatomical terms of location|proximal]] muscle [[Muscle weakness|weakness]], climbing stairs, sustaining [[Imbalance|balance]], elevating arms, and in later stages [[heart failure]].<ref name="pmid203012989" /><ref name="pmid23097603">{{cite journal |vauthors=Passamano L, Taglia A, Palladino A, Viggiano E, D'Ambrosio P, Scutifero M, Rosaria Cecio M, Torre V, DE Luca F, Picillo E, Paciello O, Piluso G, Nigro G, Politano L |title=Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients |journal=Acta Myol |volume=31 |issue=2 |pages=121–5 |date=October 2012 |pmid=23097603 |pmc=3476854 |doi= |url=}}</ref>
* The most common complications in Becker's muscular dystrophy are [[Cardiac failure|cardiac]] and [[Respiratory failure|respiratory]] failure, [[Pneumonia|pneumonias]], and in rare cases [[cognitive impairment]].
* The most common complications in Becker's muscular dystrophy are [[Cardiac failure|cardiac]] and [[Respiratory failure|respiratory]] failure, [[Pneumonia|pneumonias]], and in rare cases [[cognitive impairment]].<ref name="pmid975594" /><ref name="urlwww.mda.org">{{cite web |url=https://www.mda.org/sites/default/files/publications/Facts_DMD-BMD_P-211_0.pdf |title=www.mda.org |format= |work= |accessdate=}}</ref>
* [[Prognosis]] is generally poor, depending on [[spectrum]] of Becker's muscular dystrophy, but much better that [[Duchenne muscular dystrophy]]. In 2002, the [[Survival analysis|survival]] rate at age 20 was 60%.
* [[Prognosis]] is generally poor, depending on [[spectrum]] of Becker's muscular dystrophy, but much better that [[Duchenne muscular dystrophy]]. In 2002, the [[Survival analysis|survival]] rate at age 20 was 60%.<ref name="pmid17162189" /><ref name="urlPathology Outlines - Becker muscular dystrophy">{{cite web |url=https://www.pathologyoutlines.com/topic/musclebeckermusculardystrophy.html |title=Pathology Outlines - Becker muscular dystrophy |format= |work= |accessdate=}}</ref>
* If left [[untreated]], the majority of patients with Becker's muscular dystrophy may die due to [[Cardiac failure|cardiac]] and [[Respiratory failure|respiratory]] failure in their mid-40's.
* If left [[untreated]], the majority of patients with Becker's muscular dystrophy may die due to [[Cardiac failure|cardiac]] and [[Respiratory failure|respiratory]] failure in their mid-40's.<ref name="pmid203012989">{{cite journal |vauthors=Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, Darras BT, Urion DK, Ghosh PS |title= |journal= |volume= |issue= |pages= |date= |pmid=20301298 |doi= |url=}}</ref>
* Cradiac, respiratory, and orthopedic care has greatly improved in last years for patients with Becker disease, this, increasing the life span in these individuals.<ref name=":4" />
* Cradiac, respiratory, and orthopedic care has greatly improved in last years for patients with Becker disease, this, increasing the life span in these individuals.<ref name="pmid2030129814">{{cite journal |vauthors=Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, Darras BT, Urion DK, Ghosh PS |title= |journal= |volume= |issue= |pages= |date= |pmid=20301298 |doi= |url=}}</ref>


<br />
<br />


== Diagnosis ==
== Diagnosis ==
The diagnosis of Becker's muscular dystrophy is made with a classic clinical presentation plus elevated [[Creatine kinase|CK]], [[Molecular genetic analysis|molecular genetic testing]], or [[muscle biopsy]].
The diagnosis of Becker's muscular dystrophy is made with a classic clinical presentation plus elevated [[Creatine kinase|CK]], [[Molecular genetic analysis|molecular genetic testing]], or [[muscle biopsy]].<ref name="pmid2030129816" />


=== Symptoms ===
=== Symptoms ===
Symptoms of Becker's muscular dystrophy may include the following:
Symptoms of Becker's muscular dystrophy may include the following:


* [[Anatomical terms of location|Proximal]] [[muscle weakness]]
* [[Anatomical terms of location|Proximal]] [[muscle weakness]]<ref name="urlwww.mda.org" /><ref name="pmid23097603" />
* [[Myalgia|Myalgias]]
* [[Myalgia|Myalgias]]<ref name="urlwww.mda.org" /><ref name="pmid2030129816" />
* [[Cramp|Muscle cramps]]
* [[Cramp|Muscle cramps]]<ref name="urlwww.mda.org" />
* [[Imbalance]]
* [[Imbalance]]<ref name="urlwww.mda.org" /><ref name="pmid2030129816">{{cite journal |vauthors=Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, Darras BT, Urion DK, Ghosh PS |title= |journal= |volume= |issue= |pages= |date= |pmid=20301298 |doi= |url=}}</ref>
* [[Toe walking]]
* [[Toe walking]]<ref name="pmid23097603" />
* Difficulty raising from a chair
* Difficulty raising from a chair<ref name="urlwww.mda.org" /><ref name="pmid23097603" /><ref name="pmid2030129816" />
* Difficulty [[climbing]] stairs
* Difficulty [[climbing]] stairs<ref name="urlwww.mda.org" /><ref name="pmid2030129816" />
* Difficulty raising the arms
* Difficulty raising the arms<ref name="urlwww.mda.org" /><ref name="pmid23097603" />
* [[Cardiac failure|Heart failure]]
* [[Cardiac failure|Heart failure]]<ref name="urlwww.mda.org" />
* [[Dyspnea]]
* [[Dyspnea]]<ref name="pmid2030129816" />


=== Physical Examination ===
=== Physical Examination ===
Patients with Becker's muscular dystrophy usually adapt a posture with shoulders held back, abdomen stuck out, and lumbar hyperlordosis.
Patients with Becker's muscular dystrophy usually adopt a posture with shoulders held back, abdomen stuck out, and lumbar hyperlordosis.<ref name="pmid2760082" />


Physical examination may be remarkable for:
Physical examination may be remarkable for:


*Calf [[Hypertrophy (medical)|hypertrophy]]
*Calf [[Hypertrophy (medical)|hypertrophy]]<ref name="urlwww.mda.org" />
*[[Gowers sign]]
*[[Gowers sign]]<ref name="urlwww.mda.org" />
*[[Cardiac arrhythmia|Arrythmias]]
*[[Cardiac arrhythmia|Arrythmias]]<ref name="urlwww.mda.org" />


=== Laboratory Findings ===
=== Laboratory Findings ===
An elevated [[Creatine kinase|CK]] is typical in Becker's muscular [[dystrophy]], with a peak around 10-15 years of age.<ref name=":5" />
An elevated [[Creatine kinase|CK]] is typical in Becker's muscular [[dystrophy]], with a peak around 10-15 years of age.<ref name="pmid243054472" />


Other laboratory finding consistent with Becker's muscular dystrophy may be:
Other laboratory findings consistent with Becker's muscular dystrophy may be:


* Elevated [[Alanine transaminase|ALT]]/[[ASTL|AST]]<ref name=":5" />
* Elevated [[Alanine transaminase|ALT]]/[[ASTL|AST]]<ref name="pmid243054472">{{cite journal |vauthors=Wicklund MP |title=The muscular dystrophies |journal=Continuum (Minneap Minn) |volume=19 |issue=6 Muscle Disease |pages=1535–70 |date=December 2013 |pmid=24305447 |doi=10.1212/01.CON.0000440659.41675.8b |url=}}</ref>
* [[Myoglobinuria]] when strenous [[Physical exercise|physical activity]]<ref name=":5" />
* [[Myoglobinuria]] when strenous [[Physical exercise|physical activity]]<ref name="pmid170419062">{{cite journal |vauthors=Deburgrave N, Daoud F, Llense S, Barbot JC, Récan D, Peccate C, Burghes AH, Béroud C, Garcia L, Kaplan JC, Chelly J, Leturcq F |title=Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene |journal=Hum. Mutat. |volume=28 |issue=2 |pages=183–95 |date=February 2007 |pmid=17041906 |doi=10.1002/humu.20422 |url=}}</ref>
* Normal [[Gamma-glutamyl transpeptidase|GGT]]
* Normal [[Gamma-glutamyl transpeptidase|GGT]]<ref name="pmid26022459">{{cite journal |vauthors=Lee SH, Lee JH, Lee KA, Choi YC |title=Clinical and Genetic Characterization of Female Dystrophinopathy |journal=J Clin Neurol |volume=11 |issue=3 |pages=248–51 |date=July 2015 |pmid=26022459 |pmc=4507379 |doi=10.3988/jcn.2015.11.3.248 |url=}}</ref>


=== Hystopathology ===
=== Hystopathology ===
[[Histological section|Histologic]] findings in Becker's muscular may be:
[[Histological section|Histologic]] findings in Becker's muscular may be:


* [[Atrophy|Atrophic]] small [[myofibers]]<ref name=":5" />
* [[Atrophy|Atrophic]] small [[myofibers]]<ref name="SarkozyBushby20143" />
* [[Skeletal muscle|Muscle fibers]] [[necrosis]] and regeneration<ref name=":5" />
* [[Skeletal muscle|Muscle fibers]] [[necrosis]] and regeneration<ref name="SarkozyBushby20143" /><ref name="urlPathology Outlines - Becker muscular dystrophy" />
* [[Endomysium|Endomysial]] [[fibrosis]] and fatty replacement of [[muscle]]<ref name=":5" />
* [[Endomysium|Endomysial]] [[fibrosis]] and fatty replacement of [[muscle]]<ref name="SarkozyBushby20143" />
* [[Inflammation]]<ref name=":5" />
* [[Inflammation]]<ref name="SarkozyBushby20143" /><ref name="urlPathology Outlines - Becker muscular dystrophy" />


=== EMG ===
=== EMG ===
[[Electromyography|EMG]] in Becker's muscular [[dystrophy]], may reveal myopathic [[motor units]] with or without [[muscle membrane]] instability.
[[Electromyography|EMG]] in Becker's muscular [[dystrophy]], may reveal myopathic [[motor units]] with or without [[muscle membrane]] instability.<ref name="pmid243054472" /><ref name="pmid30356714">{{cite journal |vauthors=Naddaf E, Milone M, Mauermann ML, Mandrekar J, Litchy WJ |title=Muscle Biopsy and Electromyography Correlation |journal=Front Neurol |volume=9 |issue= |pages=839 |date=2018 |pmid=30356714 |pmc=6189315 |doi=10.3389/fneur.2018.00839 |url=}}</ref>


=== Echocardiography ===
=== Echocardiography ===
[[Echocardiography|Echocardiogram]] should be done at the time of diagnosis.
[[Echocardiography|Echocardiogram]] should be done at the time of diagnosis.<ref name="pmid30356714" /><ref name="pmid2030129817">{{cite journal |vauthors=Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, Darras BT, Urion DK, Ghosh PS |title= |journal= |volume= |issue= |pages= |date= |pmid=20301298 |doi= |url=}}</ref>


=== Imaging Findings ===
=== Imaging Findings ===
There are no [[X-ray]] findings characteristic with  with Becker's muscular dystrophy, but [[scoliosis]] may be found.     
There are no [[X-ray]] findings characteristic with  with Becker's muscular dystrophy, but [[scoliosis]] may be found.<ref name="pmid2760082">{{cite journal |vauthors=Smith AD, Koreska J, Moseley CF |title=Progression of scoliosis in Duchenne muscular dystrophy |journal=J Bone Joint Surg Am |volume=71 |issue=7 |pages=1066–74 |date=August 1989 |pmid=2760082 |doi= |url=}}</ref>      
<br />
<br />
== Treatment ==
== Treatment ==
Line 144: Line 143:
=== Medical Therapy ===
=== Medical Therapy ===


* There is no definitive treatment for Becker's muscular [[dystrophy]]; treatment will be [[Multidisciplinary care|multidisciplinary]] depending on [[Comorbidity|comorbidities]]; the mainstay of therapy is [[supportive care]].
* There is no definitive treatment for Becker's muscular [[dystrophy]]; treatment will be [[Multidisciplinary care|multidisciplinary]] depending on [[Comorbidity|comorbidities]]; the mainstay of therapy is [[supportive care]].<ref name="SarkozyBushby20144" />
* [[Corticosteroid medications|Corticosteroids]] have shown to improve strength in other [[dystrophinopathies]], but its efficacy on Beckers muscular dystrophy is uncertain. To measure improvement with [[corticosteroid]] therapy, [[timed muscle function tests]], [[pulmonary function tests]], and age at loss of [[independent ambulation]] are registered.<ref name="pmid2030129812" />
* [[Corticosteroid medications|Corticosteroids]] have shown to improve strength in other [[dystrophinopathies]], but its efficacy on Beckers muscular dystrophy is uncertain. To measure improvement with [[corticosteroid]] therapy, [[timed muscle function tests]], [[pulmonary function tests]], and age at loss of [[independent ambulation]] are registered.<ref name="pmid2030129817" />
* The management of [[Scoliosis (patient information)|scoliosis]] is bracing and [[surgery]] in some cases.
* The management of [[Scoliosis (patient information)|scoliosis]] is bracing and [[surgery]] in some cases.<ref name="urlPathology Outlines - Becker muscular dystrophy" />
* [[Beta-blockers]], [[ARBs|angiotensin II-receptor blockers]], and [[ACE inhibitor|ACE inhibitors]] are used to improve [[ventricular function]] in patients with Becker's muscular [[dystrophy]] when [[Ejection fraction|EF]] is less than 55%.
* [[Beta-blockers]], [[ARBs|angiotensin II-receptor blockers]], and [[ACE inhibitor|ACE inhibitors]] are used to improve [[ventricular function]] in patients with Becker's muscular [[dystrophy]] when [[Ejection fraction|EF]] is less than 55%.<ref name="SarkozyBushby20144">{{cite journal|last1=Sarkozy|first1=A.|last2=Bushby|first2=K.|last3=Mercuri|first3=E.|title=Muscular Dystrophies|year=2014|doi=10.1016/B978-0-12-801238-3.05597-5}}</ref>
* [[Physical exercise|Low impact exercise]] (eg. [[swimming]]) should be advised. If [[myalgia]] presents, [[Physical exercise|physical activity]] should be reduced and [[myoglobinuria]] cheked out.
* [[Physical exercise|Low impact exercise]] (eg. [[swimming]]) should be advised. If [[myalgia]] presents, [[Physical exercise|physical activity]] should be reduced and [[myoglobinuria]] cheked out.<ref name="pmid2030129817" />


=== Surgery ===
=== Surgery ===


* [[Heart transplantation|Cardiac transplantation]] may be requiered in patients with severe [[Dilated cardiomyopathy classification|dilated cardiomyopathy]].
* [[Heart transplantation|Cardiac transplantation]] may be requiered in patients with severe [[Dilated cardiomyopathy classification|dilated cardiomyopathy]].<ref name="pmid2030129817" />


* Severe or incapacitating [[scoliosis]] may be corrected with [[surgery]].
* Severe or incapacitating [[scoliosis]] may be corrected with [[surgery]].<ref name="pmid2030129817" />


=== Primary Prevention ===
=== Primary Prevention ===
There are no primary preventive measures available for Becker's muscular [[dystrophy]].
There are no primary preventive measures available for Becker's muscular [[dystrophy]].<ref name="urlPathology Outlines - Becker muscular dystrophy" />


=== Secondary Prevention ===
=== Secondary Prevention ===


* Once diagnosed, patients with Becker's muscular [[dystrophy]] are followed-up every year or two years by [[cardiology]]. Follow-up testing includes [[pulmonary function tests]], measurement of [[scoliosis]], wheelchair depence, and [[cardiac assesment]].<ref name="pmid2030129810" />
* Once diagnosed, patients with Becker's muscular [[dystrophy]] are followed-up every year or two years by [[cardiology]]. Follow-up testing includes [[pulmonary function tests]], measurement of [[scoliosis]], wheelchair depence, and [[cardiac assesment]].<ref name="pmid2030129817" />
*Annual [[Influenza vaccine|influenza]] and [[Pneumococcal Vaccine 13-Valent|pneumococcal]] vaccines should be given, as well [[vitamin D]] and [[calcium]] to prevent fractures.<ref name="pmid2030129810" />
*Annual [[Influenza vaccine|influenza]] and [[Pneumococcal Vaccine 13-Valent|pneumococcal]] vaccines should be given, as well [[vitamin D]] and [[calcium]] to prevent fractures.<ref name="pmid2030129817" />
 
 


{{Muscular Dystrophy}}<br />
==References==
<br />
<br />
==References==
==References== 
<nowiki>{{Reflist|2}}</nowiki>
<nowiki>{{Reflist|2}}</nowiki><br />
<br />
<br />
{{Muscular Dystrophy}}
[[it:Distrofia muscolare di Becker]]
[[nl:Becker spierdystrofie]]
[[no:Beckers muskeldystrofi]]
[[fi:Beckerin lihasdystrofia]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}


[[Category:Disease]]
[[Category:Disease]]

Latest revision as of 17:24, 4 September 2020


WikiDoc Resources for Becker's muscular dystrophy

Articles

Most recent articles on Becker's muscular dystrophy

Most cited articles on Becker's muscular dystrophy

Review articles on Becker's muscular dystrophy

Articles on Becker's muscular dystrophy in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Becker's muscular dystrophy

Images of Becker's muscular dystrophy

Photos of Becker's muscular dystrophy

Podcasts & MP3s on Becker's muscular dystrophy

Videos on Becker's muscular dystrophy

Evidence Based Medicine

Cochrane Collaboration on Becker's muscular dystrophy

Bandolier on Becker's muscular dystrophy

TRIP on Becker's muscular dystrophy

Clinical Trials

Ongoing Trials on Becker's muscular dystrophy at Clinical Trials.gov

Trial results on Becker's muscular dystrophy

Clinical Trials on Becker's muscular dystrophy at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Becker's muscular dystrophy

NICE Guidance on Becker's muscular dystrophy

NHS PRODIGY Guidance

FDA on Becker's muscular dystrophy

CDC on Becker's muscular dystrophy

Books

Books on Becker's muscular dystrophy

News

Becker's muscular dystrophy in the news

Be alerted to news on Becker's muscular dystrophy

News trends on Becker's muscular dystrophy

Commentary

Blogs on Becker's muscular dystrophy

Definitions

Definitions of Becker's muscular dystrophy

Patient Resources / Community

Patient resources on Becker's muscular dystrophy

Discussion groups on Becker's muscular dystrophy

Patient Handouts on Becker's muscular dystrophy

Directions to Hospitals Treating Becker's muscular dystrophy

Risk calculators and risk factors for Becker's muscular dystrophy

Healthcare Provider Resources

Symptoms of Becker's muscular dystrophy

Causes & Risk Factors for Becker's muscular dystrophy

Diagnostic studies for Becker's muscular dystrophy

Treatment of Becker's muscular dystrophy

Continuing Medical Education (CME)

CME Programs on Becker's muscular dystrophy

International

Becker's muscular dystrophy en Espanol

Becker's muscular dystrophy en Francais

Business

Becker's muscular dystrophy in the Marketplace

Patents on Becker's muscular dystrophy

Experimental / Informatics

List of terms related to Becker's muscular dystrophy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Moises Romo, M.D.

Overview

Former "pseudohypertrophic muscular dystrophy", now Becker's muscular dystrophy, is a genetic neuromuscular condition characterized by slowly progresive weakness and atrophy of skeletal (mostly legs and pelvis) and cardiac muscles.

Historical Perspective

Pathophysiology

Clinical Features

Unlike Duchenne muscular dystrophy, Becker's muscular dystrophy (BMD) phenotype presents at a later age, widely variable onset from early childhood to late adulthood, most of them falling in puberty range. Most of the patients will requiere a wheelchair after age 16.[12]

Clinical presentation Becker's muscular dystrophy include:

There is an abcense of fasciculations, and this finding may exclude BMD[13][14]

CNS is rarely afected in Becker's muscular dystrophy, for this reason, intelligence is usually spared.[12][17]

Most of women are asymptomatic carriers, with very rare cases presenting the classic symptoms.[12][9]

Differentiating Becker's muscular dystrophy from other Diseases

Becker's muscular dystrophy must be differentiated from other diseases that cause skelletal and cardiac muscle afection, such as:

Screening


Epidemiology and Demographics

  • The prevalence of Becker's muscular dystrophy is approximately 1-3 per 100,000 individuals.
  • The incidence of Becker's muscular dystrophy is approximately 3-6 per 100,000 male births worldwide.

Age

Becker's muscular dystrophy is diagnosed in 85% of patients by age 25.[21]

Gender

Becker's muscular dystrophy affects mostly men, women are carriers almost exclusively (except rare situation).[22]

Race

  • Becker's muscular dystrophy usually affects individuals of the hispanic race.[23][24]
  • Asian individuals are less likely to develop Becker's muscular dystrophy.[23][24]

Risk Factors

Natural History, Complications and Prognosis


Diagnosis

The diagnosis of Becker's muscular dystrophy is made with a classic clinical presentation plus elevated CK, molecular genetic testing, or muscle biopsy.[33]

Symptoms

Symptoms of Becker's muscular dystrophy may include the following:

Physical Examination

Patients with Becker's muscular dystrophy usually adopt a posture with shoulders held back, abdomen stuck out, and lumbar hyperlordosis.[34]

Physical examination may be remarkable for:

Laboratory Findings

An elevated CK is typical in Becker's muscular dystrophy, with a peak around 10-15 years of age.[35]

Other laboratory findings consistent with Becker's muscular dystrophy may be:

Hystopathology

Histologic findings in Becker's muscular may be:

EMG

EMG in Becker's muscular dystrophy, may reveal myopathic motor units with or without muscle membrane instability.[35][38]

Echocardiography

Echocardiogram should be done at the time of diagnosis.[38][39]

Imaging Findings

There are no X-ray findings characteristic with with Becker's muscular dystrophy, but scoliosis may be found.[34]

Treatment

Medical Therapy

Surgery

Primary Prevention

There are no primary preventive measures available for Becker's muscular dystrophy.[31]

Secondary Prevention

Template:Muscular Dystrophy

References


==References== 

{{Reflist|2}}

  1. ↑ Zeidman LA, Kondziella D (April 2014). "Peter Becker and his Nazi past: the man behind Becker muscular dystrophy and Becker myotonia". J. Child Neurol. 29 (4): 514–9. doi:10.1177/0883073813482773. PMID 23576413.
  2. ↑ "Guillaume Benjamin Amand Duchenne de Boulogne".
  3. ↑ Mercuri E, Bönnemann CG, Muntoni F (November 2019). "Muscular dystrophies". Lancet. 394 (10213): 2025–2038. doi:10.1016/S0140-6736(19)32910-1. PMID 31789220.
  4. ↑ 4.0 4.1 Hoffman, Eric P.; Brown, Robert H.; Kunkel, Louis M. (1987). "Dystrophin: The protein product of the duchenne muscular dystrophy locus". Cell. 51 (6): 919–928. doi:10.1016/0092-8674(87)90579-4. ISSN 0092-8674.
  5. ↑ 5.0 5.1 5.2 5.3 5.4 5.5 Sarkozy, A.; Bushby, K.; Mercuri, E. (2014). "Muscular Dystrophies". doi:10.1016/B978-0-12-801238-3.05597-5.
  6. ↑ "Becker muscular dystrophy | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program".
  7. ↑ 7.0 7.1 Wicklund MP (December 2013). "The muscular dystrophies". Continuum (Minneap Minn). 19 (6 Muscle Disease): 1535–70. doi:10.1212/01.CON.0000440659.41675.8b. PMID 24305447.
  8. ↑ Iannaccone, Susan T.; Castro, Diana (2013). "Congenital Muscular Dystrophies and Congenital Myopathies". CONTINUUM: Lifelong Learning in Neurology. 19: 1509–1534. doi:10.1212/01.CON.0000440658.03557.f1. ISSN 1080-2371.
  9. ↑ 9.0 9.1 Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean L, Stephens K, Amemiya A, Darras BT, Urion DK, Ghosh PS. PMID 20301298. Vancouver style error: initials (help); Missing or empty |title= (help)
  10. ↑ Invalid <ref> tag; no text was provided for refs named pmid236206492
  11. ↑ Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean L, Stephens K, Amemiya A, Darras BT, Urion DK, Ghosh PS. PMID 20301298. Vancouver style error: initials (help); Missing or empty |title= (help)
  12. ↑ 12.0 12.1 12.2 12.3 12.4 12.5 Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean L, Stephens K, Amemiya A, Darras BT, Urion DK, Ghosh PS. PMID 20301298. Vancouver style error: initials (help); Missing or empty |title= (help)
  13. ↑ 13.0 13.1 13.2 Sarkozy, A.; Bushby, K.; Mercuri, E. (2014). "Muscular Dystrophies". doi:10.1016/B978-0-12-801238-3.05597-5.
  14. ↑ 14.0 14.1 14.2 Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean L, Stephens K, Amemiya A, Darras BT, Urion DK, Ghosh PS. PMID 20301298. Vancouver style error: initials (help); Missing or empty |title= (help)
  15. ↑ 15.0 15.1 Wicklund MP (December 2013). "The muscular dystrophies". Continuum (Minneap Minn). 19 (6 Muscle Disease): 1535–70. doi:10.1212/01.CON.0000440659.41675.8b. PMID 24305447.
  16. ↑ 16.0 16.1 16.2 16.3 16.4 16.5 Invalid <ref> tag; no text was provided for refs named pmid17162189
  17. ↑ Sarkozy, A.; Bushby, K.; Mercuri, E. (2014). "Muscular Dystrophies". doi:10.1016/B978-0-12-801238-3.05597-5.
  18. ↑ 18.0 18.1 Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean L, Stephens K, Amemiya A, Darras BT, Urion DK, Ghosh PS. PMID 20301298. Vancouver style error: initials (help); Missing or empty |title= (help)
  19. ↑ 19.0 19.1 Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean L, Stephens K, Amemiya A, Darras BT, Urion DK, Ghosh PS. PMID 20301298. Vancouver style error: initials (help); Missing or empty |title= (help)
  20. ↑ 20.0 20.1 Deburgrave N, Daoud F, Llense S, Barbot JC, Récan D, Peccate C, Burghes AH, Béroud C, Garcia L, Kaplan JC, Chelly J, Leturcq F (February 2007). "Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene". Hum. Mutat. 28 (2): 183–95. doi:10.1002/humu.20422. PMID 17041906.
  21. ↑ Bushby KM, Thambyayah M, Gardner-Medwin D (April 1991). "Prevalence and incidence of Becker muscular dystrophy". Lancet. 337 (8748): 1022–4. doi:10.1016/0140-6736(91)92671-n. PMID 1673177.
  22. ↑ Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean L, Stephens K, Amemiya A, Darras BT, Urion DK, Ghosh PS. PMID 20301298. Vancouver style error: initials (help); Missing or empty |title= (help)
  23. ↑ 23.0 23.1 "Prevalence of Duchenne / Becker Muscular Dystrophies | CDC".
  24. ↑ 24.0 24.1 "Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years - four states, 2007". MMWR Morb. Mortal. Wkly. Rep. 58 (40): 1119–22. October 2009. PMID 19834452.
  25. ↑ "Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years - four states, 2007". MMWR Morb. Mortal. Wkly. Rep. 58 (40): 1119–22. October 2009. PMID 19834452.
  26. ↑ Barakat-Haddad C, Shin S, Candundo H, Lieshout PV, Martino R (July 2017). "A systematic review of risk factors associated with muscular dystrophies". Neurotoxicology. 61: 55–62. doi:10.1016/j.neuro.2016.03.007. PMID 27018093.
  27. ↑ 27.0 27.1 Emery AE, Skinner R (October 1976). "Clinical studies in benign (Becker type) X-linked muscular dystrophy". Clin. Genet. 10 (4): 189–201. doi:10.1111/j.1399-0004.1976.tb00033.x. PMID 975594.
  28. ↑ 28.0 28.1 Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean L, Stephens K, Amemiya A, Darras BT, Urion DK, Ghosh PS. PMID 20301298. Vancouver style error: initials (help); Missing or empty |title= (help)
  29. ↑ 29.0 29.1 29.2 29.3 29.4 Passamano L, Taglia A, Palladino A, Viggiano E, D'Ambrosio P, Scutifero M, Rosaria Cecio M, Torre V, DE Luca F, Picillo E, Paciello O, Piluso G, Nigro G, Politano L (October 2012). "Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients". Acta Myol. 31 (2): 121–5. PMC 3476854. PMID 23097603.
  30. ↑ 30.00 30.01 30.02 30.03 30.04 30.05 30.06 30.07 30.08 30.09 30.10 30.11 "www.mda.org" (PDF).
  31. ↑ 31.0 31.1 31.2 31.3 31.4 "Pathology Outlines - Becker muscular dystrophy".
  32. ↑ Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean L, Stephens K, Amemiya A, Darras BT, Urion DK, Ghosh PS. PMID 20301298. Vancouver style error: initials (help); Missing or empty |title= (help)
  33. ↑ 33.0 33.1 33.2 33.3 33.4 33.5 Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean L, Stephens K, Amemiya A, Darras BT, Urion DK, Ghosh PS. PMID 20301298. Vancouver style error: initials (help); Missing or empty |title= (help)
  34. ↑ 34.0 34.1 Smith AD, Koreska J, Moseley CF (August 1989). "Progression of scoliosis in Duchenne muscular dystrophy". J Bone Joint Surg Am. 71 (7): 1066–74. PMID 2760082.
  35. ↑ 35.0 35.1 35.2 Wicklund MP (December 2013). "The muscular dystrophies". Continuum (Minneap Minn). 19 (6 Muscle Disease): 1535–70. doi:10.1212/01.CON.0000440659.41675.8b. PMID 24305447.
  36. ↑ Deburgrave N, Daoud F, Llense S, Barbot JC, Récan D, Peccate C, Burghes AH, Béroud C, Garcia L, Kaplan JC, Chelly J, Leturcq F (February 2007). "Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene". Hum. Mutat. 28 (2): 183–95. doi:10.1002/humu.20422. PMID 17041906.
  37. ↑ Lee SH, Lee JH, Lee KA, Choi YC (July 2015). "Clinical and Genetic Characterization of Female Dystrophinopathy". J Clin Neurol. 11 (3): 248–51. doi:10.3988/jcn.2015.11.3.248. PMC 4507379. PMID 26022459.
  38. ↑ 38.0 38.1 Naddaf E, Milone M, Mauermann ML, Mandrekar J, Litchy WJ (2018). "Muscle Biopsy and Electromyography Correlation". Front Neurol. 9: 839. doi:10.3389/fneur.2018.00839. PMC 6189315. PMID 30356714.
  39. ↑ 39.0 39.1 39.2 39.3 39.4 39.5 39.6 Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean L, Stephens K, Amemiya A, Darras BT, Urion DK, Ghosh PS. PMID 20301298. Vancouver style error: initials (help); Missing or empty |title= (help)
  40. ↑ 40.0 40.1 Sarkozy, A.; Bushby, K.; Mercuri, E. (2014). "Muscular Dystrophies". doi:10.1016/B978-0-12-801238-3.05597-5.
Retrieved from "https://www.wikidoc.org/index.php?title=Becker%27s_muscular_dystrophy&oldid=1659369"